drugset / Trial / NCT02455609

Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain

NCT02455609

Phase 2/3 Unknown 90 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

Currently, opioids are widely used for pain relief, but they often provide sub-optimal analgesia with occasional serious side effects. Preservative-free ketamine hydrochloride was introduced as a spinal anesthetic more than twenty years ago and found to have advantages over local anesthetics. Intrathecal dexmedetomidine provides an analgesic effect in postoperative pain without severe sedation. The objectives of this study were to compare the efficacy and safety of intrathecally administered dexmedetomidine, ketamine, or their combination when added to bupivacaine for postoperative analgesia in major abdominal cancer surgery.

Timeline

Start
2015-03
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 10 mg Intrathecal
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Ketamine Small molecule 0.1 mg/kg Intrathecal

Indications

No indication recorded.